BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37515959)

  • 21. MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension.
    Carregal-Romero S; Fadón L; Berra E; Ruíz-Cabello J
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-coding RNAs: Emerging from the discovery to therapeutic applications.
    Baptista B; Riscado M; Queiroz JA; Pichon C; Sousa F
    Biochem Pharmacol; 2021 Jul; 189():114469. PubMed ID: 33577888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-coding RNAs and respiratory disease.
    Mestdagh P; Vandesompele J; Brusselle G; Vermaelen K
    Thorax; 2015 Apr; 70(4):388-90. PubMed ID: 25378544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-targeted therapeutics for lung cancer treatment.
    Xue J; Yang J; Luo M; Cho WC; Liu X
    Expert Opin Drug Discov; 2017 Feb; 12(2):141-157. PubMed ID: 27866431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies and challenges for non-viral delivery of non-coding RNAs to the heart.
    Vilaça A; de Windt LJ; Fernandes H; Ferreira L
    Trends Mol Med; 2023 Jan; 29(1):70-91. PubMed ID: 36371335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications.
    Reese M; Dhayat SA
    J Hematol Oncol; 2021 Sep; 14(1):141. PubMed ID: 34496946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer.
    Parashar D; Singh A; Gupta S; Sharma A; Sharma MK; Roy KK; Chauhan SC; Kashyap VK
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functions of non-coding RNAs in regulating cancer drug targets.
    Chai B; Ma Z; Wang X; Xu L; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):279-291. PubMed ID: 35538038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer.
    Weng M; Wu D; Yang C; Peng H; Wang G; Wang T; Li X
    Transl Res; 2017 Mar; 181():108-120. PubMed ID: 27810413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth.
    Petrek H; Yan Ho P; Batra N; Tu MJ; Zhang Q; Qiu JX; Yu AM
    Biochem Pharmacol; 2021 Jul; 189():114392. PubMed ID: 33359565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protean world of non-coding RNAs in glioblastoma.
    Paulmurugan R; Malhotra M; Massoud TF
    J Mol Med (Berl); 2019 Jul; 97(7):909-925. PubMed ID: 31129756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.
    Bijnsdorp IV; van Royen ME; Verhaegh GW; Martens-Uzunova ES
    Mol Diagn Ther; 2017 Aug; 21(4):385-400. PubMed ID: 28299719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-coding RNAs in stroke pathology, diagnostics, and therapeutics.
    Potemkin N; Clarkson AN
    Neurochem Int; 2023 Jan; 162():105467. PubMed ID: 36572063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 35. RNA (Epi)genetics in cardiovascular diseases.
    Elia L; Condorelli G
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioengineering of noncoding RNAs for research agents and therapeutics.
    Ho PY; Yu AM
    Wiley Interdiscip Rev RNA; 2016; 7(2):186-97. PubMed ID: 26763749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioengineered non-coding RNA agent (BERA) in action.
    Duan Z; Yu AM
    Bioengineered; 2016 Nov; 7(6):411-417. PubMed ID: 27415469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-coding RNAs as drug targets.
    Matsui M; Corey DR
    Nat Rev Drug Discov; 2017 Mar; 16(3):167-179. PubMed ID: 27444227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.
    Khanbabaei H; Ebrahimi S; García-Rodríguez JL; Ghasemi Z; Pourghadamyari H; Mohammadi M; Kristensen LS
    J Exp Clin Cancer Res; 2022 Sep; 41(1):278. PubMed ID: 36114510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-coding RNA in malignant tumors. A new world of tumor biomarkers and target structures in cancer cells].
    Diederichs S
    Pathologe; 2010 Oct; 31 Suppl 2():258-62. PubMed ID: 20711585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.